title: Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
abstract: Recombinant factor VIIa is a novel haemostatic agent and was originally developed to treat haemophilia patients. Successful use of the factor in a 30-year-old male patient with pelvic fracture haemorrhage is being described by the authors.
authors.affiliation: Medical Trust Hospital, Cochin, Kerala 682016.
authors.forename: Kumar K
authors.initials: KK
authors.lastname: Dhruva
authors.forename: V D
authors.initials: VD
authors.lastname: Joel
authors.forename: S
authors.initials: S
authors.lastname: Antony
authors.forename: K
authors.initials: K
authors.lastname: Vinodan
mesh_terms: D000328:Adult; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D050723:Fractures, Bone / Q000150:complications*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D010384:Pelvic Bones / Q000293:injuries*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa